TIPRANAVIR Side Effects

6767707-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Dyslipidaemia, Hepatic Enzyme Increased, Insulin Resistance, Portal Hypertension
on Jun 04, 2010 Male patient from , 54 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Tipranavir (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, dyslipidaemia, hepatic enzyme increased, insulin resistance, portal hypertension. Tipranavir dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ).

6516183-3 | Abdominal Pain Lower, Appendicitis, Immune Reconstitution Syndrome, Vomiting
Patient was taking Tipranavir (View Usage). Patient had the following side effects: abdominal pain lower, appendicitis (What is appendicitis?), immune reconstitution syndrome, vomiting on Dec 15, 2009 from Additional patient health information: Male patient , 33 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Tipranavir dosage: . During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ). Patient was hospitalized.

5670005-1 | Depression
Adverse event was reported on Mar 06, 2008 by a Male patient taking Tipranavir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: GERMANY , weighting 147.7 lb, After Tipranavir was administered, patient had the following side effects: depression (What is depression?). During the same period patient was treated with RITONAVIR CAPSULES (VIRAMUNE REFERENCE) (View Ritonavir Capsules (viramune Reference) Review and Ritonavir Capsules (viramune Reference) Label ). Patient was hospitalized.

5113047-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cytolytic Hepatitis, Hepatomegaly
on Aug 31, 2006 Male patient from FRANCE , 55 years of age, weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Tipranavir (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, hepatomegaly. Tipranavir dosage: Tpv/rtv 500/200 Mg B.i.d.. During the same period patient was treated with VIDEX (View Videx Review and Videx Label ), FUZEON (View Fuzeon Review and Fuzeon Label ). Patient was hospitalized.


5098984-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cytolytic Hepatitis, Dyspepsia, Gamma-glutamyltransferase Increased, Hepatomegaly
on Aug 31, 2006 Male patient from FRANCE , 55 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Tipranavir (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, dyspepsia, gamma-glutamyltransferase increased, hepatomegaly. Tipranavir dosage: . During the same period patient was treated with NORVIR (4.0 Dosage Form) (View Norvir Review and Norvir Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ). Patient was hospitalized.

5021531-X | Blood Hiv Rna Increased, Cardiolipin Antibody Positive, Cd4 Lymphocytes Decreased, Deep Vein Thrombosis, Dilatation Ventricular, Dizziness Exertional, Electrocardiogram T Wave Amplitude Decreased, Gallop Rhythm Present, Hypotension
Patient was taking Tipranavir (View Usage). After Tipranavir was administered, patient had the following side effects: blood hiv rna increased (What is blood hiv rna increased?), cardiolipin antibody positive, cd4 lymphocytes decreased, deep vein thrombosis (What is deep vein thrombosis?), dilatation ventricular, dizziness exertional, electrocardiogram t wave amplitude decreased, gallop rhythm present, hypotension on Jun 06, 2006 from Additional patient health information: Male patient , 35 years of age, was diagnosed with hiv infection (What is hiv infection?), ecthyma and. Tipranavir dosage: . During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ), BROAD SPECTRUM ANTIBIOTICS (View Broad-spectrum Antibiotics Review and Broad-spectrum Antibiotics Label ). Patient was hospitalized.

4814883-4 | Electrocardiogram Qt Corrected Interval Prolonged
Adverse event was reported on Oct 27, 2005 by a Male patient taking Tipranavir (View Usage) (Dosage: 500 Mg Bid Po) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 44 years of age, Patient experienced the following unwanted or unexpected effects: electrocardiogram qt corrected interval prolonged. During the same period patient was treated with NORVIR (200 Mg Bid Po) (View Norvir Review and Norvir Label ), EPZICOM (1 Tab Qd Po) (View Epzicom Review and Epzicom Label ), VIDEX EC (400mg Qd Po) (View Videx Ec Review and Videx Ec Label ), ALLEGRA (View Allegra Review and Allegra Label ), AMBIEN (View Ambien Review and Ambien Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENADRYL (View Benadryl Review and Benadryl Label ), CORAL CALCIUM (View Coral Calcium Review and Coral Calcium Label ).

4736739-8 | Gallbladder Cancer
on Jul 15, 2005 Male patient from , weighting 116.8 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Tipranavir (View Usage). Patient had the following side effects: gallbladder cancer (What is gallbladder cancer?). Tipranavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), ENFUVIRTIDE (Strength: 90mg/ml Daily Dose: 180mg/ml) (View Enfuvirtide Review and Enfuvirtide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), REQUIP (View Requip Review and Requip Label ), OMNIC (View Omnic Review and Omnic Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

4722896-6 | Anal Haemorrhage, Anal Ulcer, Diarrhoea
on Jun 23, 2005 Female patient from , weighting 172.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Tipranavir (View Usage). After Tipranavir was administered, patient had the following side effects: anal haemorrhage, anal ulcer, diarrhoea. Tipranavir dosage: Tipranavir 1000 Mg/rtv 400 Mg. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), FUZEON (View Fuzeon Review and Fuzeon Label ). Patient was hospitalized.

4709950-X | Anal Haemorrhage, Anal Ulcer, Condition Aggravated, Diarrhoea
Patient was taking Tipranavir (View Usage). Patient experienced the following unwanted or unexpected effects: anal haemorrhage, anal ulcer, condition aggravated, diarrhoea on Jun 23, 2005 from Additional patient health information: Female patient , weighting 172.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Tipranavir dosage: Tipranavir 1000 Mg/rtv 400 Mg. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), FUZEON (View Fuzeon Review and Fuzeon Label ). Patient was hospitalized.